Skip to main content
eScholarship
Open Access Publications from the University of California

Can PRAME immunohistochemistry be used to differentiate sebaceous carcinoma from basal cell carcinoma?

The data associated with this publication are not available for this reason: N/A
Abstract

The histopathology of sebaceous carcinoma (SBC) can mimic other skin neoplasms, including basal cell carcinoma (BCC).Therefore, diagnostic biomarkers are needed for a subset of cases. Normal sebaceous glands express PRAME (PRAME nuclearreceptor transcriptional regulator), a melanoma-associated biomarker.Donell et al. showed that PRAME has strong immunoreactivity with basaloid sebocytes in SBC. Ng et al. reported patchy cytoplasmic staining in the germinative sebocytes only.Sebaceous glands (H&E stain and PRAME stain)

Objective: to evaluate the utility of PRAME immunohistochemistry as a diagnostic biomarker for SBC and its usefulness in the distinction of SBC from BCC.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View